Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALTIRE II: Denosumab and Alendronic Acid in Aortic Stenosis
NCT02132026Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Nov 2014
- Primary completion
- Nov 2019
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab, alendronate in calcific aortic stenosis (AS), sponsored by University of Edinburgh. Started Nov 2014; status: completed.
02
Drugs
denosumabalendronate
03
Conditions
calcific aortic stenosis (AS)
Beyond the preview
Go deeper on NCT02132026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132026.